Global 3D Printing Medical Devices Market

3D Printing Medical Devices Market Size, Share, Growth Analysis, By Types (Surgical Guides, Prosthetics, and Others), By Component (System and Material), By Application (Wearable External Devices, Implants, and Others), By Region -Industry Forecast 2026-2033

Report ID: SQMIG35A2617 | Region: Global | Published Date: August, 2025
Pages: 176 |Tables: 89 |Figures: 71

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global 3D Printing Medical Devices Market size was valued at USD 3.59 Billion in 2024 poised to grow between USD 4.03 Billion in 2025 to USD 10.2 Billion by 2033, growing at a CAGR of 12.3% in the forecast period (2026–2033).

    the global 3D printing medical devices market outlook is competitive and marked by innovation and strategic collaboration. Key international players include Stratasys, 3D Systems, Materialise, and GE Healthcare. Stratasys focuses on expanding its healthcare portfolio through partnerships, while 3D Systems invests in bioprinting R&D. Materialise enhances its software capabilities for surgical planning, and GE Healthcare integrates 3D printing with imaging technologies to offer customized medical solutions globally. '3D Systems Corporation (USA)', 'Stratasys Ltd. (USA)', 'Materialise NV (Belgium)', 'SLM Solutions Group AG (Germany)', 'EnvisionTEC GmbH (Germany)', 'EOS GmbH (Germany)', 'Renishaw plc (United Kingdom)', 'GE Additive (USA)', 'Prodways Group (France)', 'Organovo Holdings Inc. (USA)', 'Arcam AB (a GE Additive company) (Sweden)', 'CELLINK (BICO Group) (Sweden)', 'Formlabs Inc. (USA)', 'Axial3D (United Kingdom)', 'Ricoh Company, Ltd. (Japan)'

    The growing need for patient-specific medical devices is a major driver. 3D printing enables customization based on individual anatomy, improving implant fit and surgical outcomes. This personalized approach reduces recovery time and complications, prompting healthcare providers to adopt 3D printing technologies for prosthetics, implants, and surgical guides across various medical disciplines.

    Personalization Surge in Patient-Specific Implants: The growing demand for patient-specific implants is driving innovation in the global 3D printing medical devices market trends. Healthcare providers increasingly prefer customized solutions for better anatomical fit, faster recovery, and improved surgical outcomes. This trend is fostering collaboration between hospitals and manufacturers to create precise, tailored devices using advanced imaging and printing technologies.

    Why is North America Considered a Hub for 3D-Printed Medical Innovation?

    Related Reports

    Medical 3D Printing Market
    Buy Now GET FREE SAMPLE
    3D Printing in Healthcare Market
    Buy Now GET FREE SAMPLE
    3D Printing Market
    Buy Now GET FREE SAMPLE
    3D Printed Surgical Models Market
    Buy Now GET FREE SAMPLE
    Industrial 3D Printing Market
    Buy Now GET FREE SAMPLE
    3D Printed Wearables Market
    Buy Now GET FREE SAMPLE
    3D Printing Material Market
    Buy Now GET FREE SAMPLE
    3D Printed Drugs Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global 3D Printing Medical Devices Market

    Report ID: SQMIG35A2617

    $5,300
    BUY NOW